chr13-108208673-CAATT-C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PVS1_ModeratePP5
The NM_206937.2(LIG4):c.2592_2595delAATT(p.Ile864MetfsTer25) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206937.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIG4 | NM_206937.2 | c.2592_2595delAATT | p.Ile864MetfsTer25 | frameshift_variant | Exon 3 of 3 | ENST00000442234.6 | NP_996820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251370 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461802Hom.: 0 AF XY: 0.0000138 AC XY: 10AN XY: 727194 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324 show subpopulations
ClinVar
Submissions by phenotype
DNA ligase IV deficiency Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ile864Metfs*25) in the LIG4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 48 amino acid(s) of the LIG4 protein. This variant is present in population databases (rs765317127, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with LIG4-related conditions. ClinVar contains an entry for this variant (Variation ID: 452857). This variant disrupts a region of the LIG4 protein in which other variant(s) (p.Gln904*) have been determined to be pathogenic (PMID: 34630384). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: LIG4 c.2592_2595delAATT (p.Ile864MetfsX25) results in a premature termination codon, predicted to cause a truncation of the encoded protein and predicted not involved in nonsense-mediated mRNA decay. The variant allele was found at a frequency of 2.8e-05 in 251370 control chromosomes (gnomAD). To our knowledge, no occurrence of c.2592_2595delAATT in individuals affected with Severe Combined Immunodeficiency and no experimental evidence demonstrating its impact on protein function have been reported. However, at least one nonsense variant has been found in one patient with LIG4 deficiency in HGMD (PMID: 34630384) and pathogenic variants downstream of this variant have been reported in ClinVar. ClinVar contains an entry for this variant (Variation ID: 452857). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Uncertain:1
The c.2592_2595delAATT variant in the LIG4 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes a frameshift starting with codon Isoleucine 864, changes this amino acid to a Methionine residue, and creates a premature Stop codon at position 25 of the new reading frame, denoted p.Ile864MetfsX25. This variant is predicted to cause loss of normal protein function through protein truncation. The c.2592_2595delAATT variant is observed in 5/111,658 alleles (0.0045%) from individuals of non-Finnish European ancestry in the gnomAD dataset (Lek et al., 2016). We interpret c.2592_2595delAATT as a variant of uncertain significance. -
LIG4-related disorder Other:1
Variant interpreted as Uncertain significance and reported on 04-25-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at